Sign In
Buy GENE
$0.765
+0 (+0%)
At Close: Jan 15, 2025
Genetic Technologies Announces $5.1 Million Registered Direct Offering
12:02pm, Thursday, 16'th Jul 2020
MELBOURNE, Australia, July 16, 2020 -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests,.
Genetic Technologies Provides Update on COVID-19 Disease Severity Test
12:00pm, Wednesday, 15'th Jul 2020
Highlights Genetic Technologies has filed a provisional patent for its COVID-19 Severity Risk Test with the Patent Office in AustraliaThe COVID-19 Severity Risk Test.
Genetic Technologies CEO to Participate in Investor Webinar and Q&A Session on June 24, 2020
12:00pm, Tuesday, 23'rd Jun 2020
MELBOURNE, Australia, June 23, 2020 -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”) is pleased to announce that its.
US Patent Office Grants Key Risk Test Patent
12:00pm, Thursday, 18'th Jun 2020
Issuance of US Patent No: US 10,683,549, Methods for assessing risk of developing breast cancer.Filed provisional patent for its COVID-19 Severity Risk Test, 2020901739 –.
Insider Buying: The Genetic Technologies Limited (ASX:GTG) Independent Non-Executive Chairman Just Bought 24% More Shares
08:49pm, Thursday, 04'th Jun 2020
Potential Genetic Technologies Limited (ASX:GTG) shareholders may wish to note that the Independent Non-Executive...
Genetic Technologies Announces Closing of $8.0 Million Public Offering
01:00am, Friday, 29'th May 2020
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announced the closing of its previously announced public
Genetic Technologies Announces Closing of $8.… Million Public Offering
12:00am, Friday, 29'th May 2020Genetic Technologies Announces Offering of 4M ADS's @$2/ADS
09:41am, Wednesday, 27'th May 2020Mid-Afternoon Market Update: Crude Oil Up 2%; argenx Shares Spike Higher
06:32pm, Tuesday, 26'th May 2020Mid-Day Market Update: Dow Jumps Over 600 Points; BioLineRx Shares Plunge
04:21pm, Tuesday, 26'th May 2020Mid-Morning Market Update: Markets Open Higher; AutoZone Beats Q3 Expectations
02:16pm, Tuesday, 26'th May 2020Genetic Technologies Announces Pricing of $8.0 Million Public Offering, $2 Per Share
01:23pm, Tuesday, 26'th May 2020Genetic Technologies Announces Pricing of $8.0 Million Public Offering
01:22pm, Tuesday, 26'th May 2020
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announced that it has priced a public offering of 4,000,
